SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 17.90 |
| Enterprise Value ($M) | 13.90 |
| Book Value ($M) | 8.59 |
| Book Value / Share | 0.12 |
| Price / Book | 2.08 |
| NCAV ($M) | -0.68 |
| NCAV / Share | -0.01 |
| Price / NCAV | -26.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.27 |
| Return on Assets (ROA) | -0.95 |
| Return on Equity (ROE) | -1.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.84 |
| Current Ratio | 1.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.70 |
| Assets | 15.97 |
| Liabilities | 7.38 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ho William Tai-Wei | 5.60 | 31.10 | |
| 13G | Alyeska Investment Group, L.P. | 9.90 | ||
| 13G/A | Hirschman Orin | 8.50 | -8.10 | |
| 13D/A | BIOS Fund II, LP | 23.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 501,935 | 1,417,843 | 35.40 | |
| 430,388 | 1,284,549 | 33.50 | |
| 363,538 | 960,648 | 37.84 | |
| 417,108 | 1,110,770 | 37.55 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMNM – Immunome, Inc. | IMNN – Imunon, Inc. |
| IMTX – Immatics N.V. | INDP – Indaptus Therapeutics, Inc. |
| INKT – MiNK Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io